Open AccessNeoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
Author(s) -
Maohui Yan,
Xiaobin Hou,
Baiqiang Cai,
Baolin Qu,
Xiaomin Dai,
Fang Liu
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i24.6315
Subject(s) - medicine , esophageal squamous cell carcinoma , chemoradiotherapy , basal cell , neoadjuvant therapy , carcinoma , esophagectomy , oncology , surgery , esophageal cancer , radiation therapy , cancer , breast cancer
In recent years, neoadjuvant chemoradiotherapy (NCRT) combined with surgery has been gradually applied in patients with locally advanced thoracic esophageal cancer, but its effectiveness and safety remains unclear. In this clinical trial, we prospectively investigated the efficacy and safety of NCRT plus surgery in the treatment of thoracic esophageal squamous cell carcinoma (TESCC).